343 related articles for article (PubMed ID: 32064884)
21. MiR-155-5p promotes oral cancer progression by targeting chromatin remodeling gene ARID2.
Wu M; Duan Q; Liu X; Zhang P; Fu Y; Zhang Z; Liu L; Cheng J; Jiang H
Biomed Pharmacother; 2020 Feb; 122():109696. PubMed ID: 31918270
[TBL] [Abstract][Full Text] [Related]
22. circ_0004872 inhibits proliferation, invasion, and glycolysis of oral squamous cell carcinoma by sponged miR-424-5p.
Dai Y; Zhu Y; Xu H
J Clin Lab Anal; 2022 Jul; 36(7):e24486. PubMed ID: 35576499
[TBL] [Abstract][Full Text] [Related]
23. miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1.
Li N; Nan CC; Zhong XY; Weng JQ; Fan HD; Sun HP; Tang S; Shi L; Huang SX
Cell Physiol Biochem; 2018; 49(4):1329-1341. PubMed ID: 30205384
[TBL] [Abstract][Full Text] [Related]
24. Baicalin exerts anti-tumor effects in oral squamous cell carcinoma by inhibiting the microRNA-106b-5p-Wnt/β-catenin pathway via upregulating disabled homolog 2.
Wang X; Zhang Y; Zhang S; Duan L
Arch Oral Biol; 2021 Oct; 130():105219. PubMed ID: 34364169
[TBL] [Abstract][Full Text] [Related]
25. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of Histone Deacetylase Inhibitor Sensitivity in Combination with Cyclin-Dependent Kinase Inhibition for the Treatment of Oral Squamous Cell Carcinoma.
Zhao B; Huang Z; Qin Z; Li Y; Wang T; Wang L; Zhou W; Yu C; Wang X; Yang S; Fan Y; Xiang R
Cell Physiol Biochem; 2019; 53(1):141-156. PubMed ID: 31237760
[TBL] [Abstract][Full Text] [Related]
27. LncRNA HOXA11-AS promotes OSCC progression by sponging miR-98-5p to upregulate YBX2 expression.
Niu X; Yang B; Liu F; Fang Q
Biomed Pharmacother; 2020 Jan; 121():109623. PubMed ID: 31731187
[TBL] [Abstract][Full Text] [Related]
28. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells.
Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL
Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461
[TBL] [Abstract][Full Text] [Related]
29. MiR-375/SLC7A11 axis regulates oral squamous cell carcinoma proliferation and invasion.
Wu Y; Sun X; Song B; Qiu X; Zhao J
Cancer Med; 2017 Jul; 6(7):1686-1697. PubMed ID: 28627030
[TBL] [Abstract][Full Text] [Related]
30. MiR-146a-5p inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma cells by regulating NF-κB signaling pathway.
Zhu FY; Gan CW; Wang MX; Sun BC; Li FJ; Qiu YH; Wang K
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3717-3723. PubMed ID: 32329848
[TBL] [Abstract][Full Text] [Related]
31. miRNA-101 Targets TGF-βR1 to Retard the Progression of Oral Squamous Cell Carcinoma.
Wang Y; Jia RZ; Diao S; He J; Jia L
Oncol Res; 2020 Mar; 28(2):203-212. PubMed ID: 31831099
[TBL] [Abstract][Full Text] [Related]
32. circBICD2 targets miR-149-5p/IGF2BP1 axis to regulate oral squamous cell carcinoma progression.
Qiu L; Zheng L; Gan C; Deng W; Sun Y; Wang T
J Oral Pathol Med; 2021 Aug; 50(7):668-680. PubMed ID: 33382158
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA LINC00958 promotes the oral squamous cell carcinoma by sponging miR-185-5p/YWHAZ.
Wang Z; Zhu X; Dong P; Cai J
Life Sci; 2020 Feb; 242():116782. PubMed ID: 31442551
[TBL] [Abstract][Full Text] [Related]
34. MiR-133a-3p Inhibits Oral Squamous Cell Carcinoma (OSCC) Proliferation and Invasion by Suppressing COL1A1.
He B; Lin X; Tian F; Yu W; Qiao B
J Cell Biochem; 2018 Jan; 119(1):338-346. PubMed ID: 28569392
[TBL] [Abstract][Full Text] [Related]
35. Targeting of cell cycle and let-7a/STAT3 pathway by niclosamide inhibits proliferation, migration and invasion in oral squamous cell carcinoma cells.
Li X; Ding R; Han Z; Ma Z; Wang Y
Biomed Pharmacother; 2017 Dec; 96():434-442. PubMed ID: 29031202
[TBL] [Abstract][Full Text] [Related]
36. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-382-5p Promotes Oral Squamous Cell Carcinoma Development and Progression by Negatively Regulating PTEN Expression.
Xu X; Jin B; Cai L; Zhang Z; Ying Y; Luo J
J Oral Maxillofac Surg; 2022 Dec; 80(12):2015-2023. PubMed ID: 36162436
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-99a-5p suppresses cell proliferation, migration, and invasion by targeting isoprenylcysteine carboxylmethyltransferase in oral squamous cell carcinoma.
Sun X; Yan H
J Int Med Res; 2021 May; 49(5):300060520939031. PubMed ID: 34038200
[TBL] [Abstract][Full Text] [Related]
39. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway.
Chen M; Zhang J
J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653
[TBL] [Abstract][Full Text] [Related]
40. miR-204-5p regulates cell proliferation and metastasis through inhibiting CXCR4 expression in OSCC.
Wang X; Li F; Zhou X
Biomed Pharmacother; 2016 Aug; 82():202-7. PubMed ID: 27470356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
